je.st
news
Abbvie 'Enhanzes' Halozyme Therapeutics coffers in potential $1.193B collaboration
2015-06-04 06:37:32| Logistics - Topix.net
Fresh off reporting good news at the American Society of Clinical Oncology annual meeting in Chicago, Halozyme Therapeutics Inc. segued into yet another global collaboration and license agreement - this time with Abbvie Inc. - that could add $1.193 billion to its coffers. The deal allows Abbvie, of North Chicago, to apply Halozyme's Enhanze delivery platform to up to nine of its compounds in return for $23 million up front to Halozyme and milestone payments totaling approximately $130 million for each collaboration target.
Tags: potential
collaboration
therapeutics
coffers
Category:Transportation and Logistics